Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Neutrophil count decreased	Investigations	Chemoimmunotherapy	16	54	16
serious	Platelet count decreased	Investigations	Chemoimmunotherapy	9	54	9
serious	Anemia	Blood and lymphatic system disorders	Chemoimmunotherapy	2	54	2
serious	Fatigue	General disorders	Chemoimmunotherapy	20	54	20
serious	Infusion related reaction	General disorders	Chemoimmunotherapy	15	54	15
serious	Myalgia	Musculoskeletal and connective tissue disorders	Chemoimmunotherapy	10	54	10
serious	Depression/Anxiety	Psychiatric disorders	Chemoimmunotherapy	8	54	8
serious	Nausea	Gastrointestinal disorders	Chemoimmunotherapy	5	54	5
serious	Headache	Nervous system disorders	Chemoimmunotherapy	2	54	2
serious	Peripheral Sensory Neuropathy	Nervous system disorders	Chemoimmunotherapy	3	54	3
serious	Elevated Liver Enzymes	Investigations	Chemoimmunotherapy	2	54	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00501644/events